XRN2 and cancer: In conclusion, at the molecular level, XRN2 deficiency combined with PARP inhibition in cancer cells exacerbates R-loop formation, elevates the generation of DSBs and replication stress, and consequently drives the activation of caspase-3 to initiate cell death.